{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:25:56Z","timestamp":1792790756813,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000070","name":"U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["ZIA EB000073"],"award-info":[{"award-number":["ZIA EB000073"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/00372qc85","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000070","name":"U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["ZIA EB000073"],"award-info":[{"award-number":["ZIA EB000073"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/00372qc85","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000070","name":"U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["ZIA EB000073"],"award-info":[{"award-number":["ZIA EB000073"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/00372qc85","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000070","name":"U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["ZIA EB000073"],"award-info":[{"award-number":["ZIA EB000073"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/00372qc85","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000070","name":"U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["ZIA EB000073"],"award-info":[{"award-number":["ZIA EB000073"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/00372qc85","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000070","name":"U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["ZIA EB000073"],"award-info":[{"award-number":["ZIA EB000073"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/00372qc85","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000070","name":"U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["ZIA EB000073"],"award-info":[{"award-number":["ZIA EB000073"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/00372qc85","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering","id":[{"id":"https:\/\/ror.org\/00372qc85","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering","id":[{"id":"https:\/\/ror.org\/00372qc85","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering","id":[{"id":"https:\/\/ror.org\/00372qc85","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering","id":[{"id":"https:\/\/ror.org\/00372qc85","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering","id":[{"id":"https:\/\/ror.org\/00372qc85","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering","id":[{"id":"https:\/\/ror.org\/00372qc85","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biomed Eng"],"DOI":"10.1038\/s41551-020-0599-5","type":"journal-article","created":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T12:04:56Z","timestamp":1597665896000},"page":"1102-1116","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":159,"title":["Burst release of encapsulated annexin A5 in tumours boosts cytotoxic T-cell responses by blocking the phagocytosis of apoptotic cells"],"prefix":"10.1038","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3911-9570","authenticated-orcid":false,"given":"Ling","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4023-7320","authenticated-orcid":false,"given":"Yunlu","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5057-3873","authenticated-orcid":false,"given":"Wenpei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4056-0347","authenticated-orcid":false,"given":"Zhen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9622-0870","authenticated-orcid":false,"given":"Xiaoyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,17]]},"reference":[{"key":"599_CR1","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41591-019-0421-7","volume":"1","author":"Z Ying","year":"2019","unstructured":"Ying, Z. et al. A safe and potent anti-CD19 CAR T cell therapy. Nat. Med. 1, 947\u2013953 (2019).","journal-title":"Nat. Med."},{"key":"599_CR2","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nbt.4195","volume":"36","author":"S Rafiq","year":"2018","unstructured":"Rafiq, S. et al. Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumour efficacy in vivo. Nat. Biotechnol. 36, 847\u2013856 (2018).","journal-title":"Nat. Biotechnol."},{"key":"599_CR3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41565-018-0319-4","volume":"14","author":"Q Chen","year":"2019","unstructured":"Chen, Q. et al. In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment. Nat. Nanotechnol. 14, 89\u201397 (2019).","journal-title":"Nat. Nanotechnol."},{"key":"599_CR4","doi-asserted-by":"crossref","first-page":"0011","DOI":"10.1038\/s41551-016-0011","volume":"1","author":"C Wang","year":"2017","unstructured":"Wang, C. et al. In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy. Nat. Biomed. Eng. 1, 0011 (2017).","journal-title":"Nat. Biomed. Eng."},{"key":"599_CR5","doi-asserted-by":"crossref","first-page":"126","DOI":"10.7150\/thno.29431","volume":"9","author":"S Gao","year":"2019","unstructured":"Gao, S. et al. Engineering nanoparticles for targeted remodeling of the tumour microenvironment to improve cancer immunotherapy. Theranostics 9, 126\u2013151 (2019).","journal-title":"Theranostics"},{"key":"599_CR6","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature24462","volume":"551","author":"VP Balachandran","year":"2017","unstructured":"Balachandran, V. P. et al. Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer. Nature 551, 512\u2013516 (2017).","journal-title":"Nature"},{"key":"599_CR7","doi-asserted-by":"crossref","first-page":"7807","DOI":"10.7150\/thno.37194","volume":"9","author":"L Zhang","year":"2019","unstructured":"Zhang, L. et al. Peptide-based materials for cancer immunotherapy. Theranostics 9, 7807\u20137825 (2019).","journal-title":"Theranostics"},{"key":"599_CR8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrc.2017.51","volume":"17","author":"M De Palma","year":"2017","unstructured":"De Palma, M., Biziato, D. & Petrova, T. V. Microenvironmental regulation of tumour angiogenesis. Nat. Rev. Cancer 17, 457\u2013474 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"599_CR9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrclinonc.2015.209","volume":"13","author":"MJ Smyth","year":"2016","unstructured":"Smyth, M. J., Ngiow, S. F., Ribas, A. & Teng, M. W. Combination cancer immunotherapies tailored to the tumour microenvironment. Nat. Rev. Clin. Oncol. 13, 143\u2013158 (2016).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"599_CR10","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1158\/1078-0432.CCR-14-1860","volume":"21","author":"GL Beatty","year":"2015","unstructured":"Beatty, G. L. & Gladney, W. L. Immune escape mechanisms as a guide for cancer immunotherapy. Clin. Cancer Res. 21, 687\u2013692 (2015).","journal-title":"Clin. Cancer Res."},{"key":"599_CR11","doi-asserted-by":"crossref","first-page":"7906","DOI":"10.7150\/thno.38425","volume":"9","author":"S Lim","year":"2019","unstructured":"Lim, S. et al. Recent advances and challenges of repurposing nanoparticle-based drug delivery systems to enhance cancer immunotherapy. Theranostics 9, 7906\u20137923 (2019).","journal-title":"Theranostics"},{"key":"599_CR12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/B978-0-12-407190-2.00007-1","volume":"119","author":"C Guo","year":"2013","unstructured":"Guo, C. et al. Therapeutic cancer vaccines: past, present, and future. Adv. Cancer Res. 119, 421\u2013475 (2013).","journal-title":"Adv. Cancer Res."},{"key":"599_CR13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7150\/thno.21278","volume":"8","author":"G Wu","year":"2018","unstructured":"Wu, G. et al. A Mucin1 C-terminal subunit-directed monoclonal antibody targets overexpressed Mucin1 in breast cancer. Theranostics 8, 78\u201391 (2018).","journal-title":"Theranostics"},{"key":"599_CR14","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nri.2017.131","volume":"18","author":"Z Hu","year":"2018","unstructured":"Hu, Z., Ott, P. A. & Wu, C. J. Towards personalized, tumour-specific, therapeutic vaccines for cancer. Nat. Rev. Immunol. 18, 168\u2013182 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"599_CR15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrc992","volume":"3","author":"AV Gudkov","year":"2003","unstructured":"Gudkov, A. V. & Komarova, E. A. The role of p53 in determining sensitivity to radiotherapy. Nat. Rev. Cancer 3, 117\u2013129 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"599_CR16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.7150\/thno.28857","volume":"9","author":"M Wu","year":"2019","unstructured":"Wu, M. et al. Self-luminescing theranostic nanoreactors with intraparticle relayed energy transfer for tumour microenvironment activated imaging and photodynamic therapy. Theranostics 9, 20\u201333 (2019).","journal-title":"Theranostics"},{"key":"599_CR17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0092-8674(02)00625-6","volume":"108","author":"RW Johnstone","year":"2002","unstructured":"Johnstone, R. W., Ruefli, A. A. & Lowe, S. W. Apoptosis: a link between cancer genetics and chemotherapy. Cell 108, 153\u2013164 (2002).","journal-title":"Cell"},{"key":"599_CR18","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1126\/science.1087621","volume":"302","author":"MO Li","year":"2003","unstructured":"Li, M. O., Sarkisian, M. R., Mehal, W. Z., Rakic, P. & Flavell, R. A. Phosphatidylserine receptor is required for clearance of apoptotic cells. Science 302, 1560\u20131563 (2003).","journal-title":"Science"},{"key":"599_CR19","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nature03964","volume":"437","author":"H Yoshida","year":"2005","unstructured":"Yoshida, H. et al. Phosphatidylserine-dependent engulfment by macrophages of nuclei from erythroid precursor cells. Nature 437, 754\u2013758 (2005).","journal-title":"Nature"},{"key":"599_CR20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/35011084","volume":"405","author":"VA Fadok","year":"2000","unstructured":"Fadok, V. A. et al. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405, 85\u201390 (2000).","journal-title":"Nature"},{"key":"599_CR21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1172\/JCI0211638","volume":"109","author":"M-LN Huynh","year":"2002","unstructured":"Huynh, M.-L. N., Fadok, V. A. & Henson, P. M. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-\u03b21 secretion and the resolution of inflammation. J. Clin. Invest. 109, 41\u201350 (2002).","journal-title":"J. Clin. Invest."},{"key":"599_CR22","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.4049\/jimmunol.0803609","volume":"184","author":"Z Wu","year":"2010","unstructured":"Wu, Z., Ma, H. M., Kukita, T., Nakanishi, Y. & Nakanishi, H. Phosphatidylserine-containing liposomes inhibit the differentiation of osteoclasts and trabecular bone loss. J. Immunol. 184, 3191\u20133201 (2010).","journal-title":"J. Immunol."},{"key":"599_CR23","first-page":"1310","volume":"70","author":"SY Proskuryakov","year":"2005","unstructured":"Proskuryakov, S. Y., Gabai, V., Konoplyannikov, A., Zamulaeva, I. & Kolesnikova, A. Immunology of apoptosis and necrosis. Biochemistry 70, 1310\u20131320 (2005).","journal-title":"Biochemistry"},{"key":"599_CR24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10495-008-0187-8","volume":"13","author":"MT Silva","year":"2008","unstructured":"Silva, M. T., Do Vale, A. & dos Santos, N. M. Secondary necrosis in multicellular animals: an outcome of apoptosis with pathogenic implications. Apoptosis 13, 463\u2013482 (2008).","journal-title":"Apoptosis"},{"key":"599_CR25","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ceb.2004.09.011","volume":"16","author":"AL Edinger","year":"2004","unstructured":"Edinger, A. L. & Thompson, C. B. Death by design: apoptosis, necrosis and autophagy. Curr. Opin. Cell Biol. 16, 663\u2013669 (2004).","journal-title":"Curr. Opin. Cell Biol."},{"key":"599_CR26","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2184.2012.00845.x","volume":"45","author":"L Ouyang","year":"2012","unstructured":"Ouyang, L. et al. Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif. 45, 487\u2013498 (2012).","journal-title":"Cell Prolif."},{"key":"599_CR27","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrc3380","volume":"12","author":"DV Krysko","year":"2012","unstructured":"Krysko, D. V. et al. Immunogenic cell death and DAMPs in cancer therapy. Nat. Rev. Cancer 12, 860\u2013875 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"599_CR28","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1515\/hsz-2014-0164","volume":"395","author":"P Davidovich","year":"2014","unstructured":"Davidovich, P., Kearney, C. J. & Martin, S. J. Inflammatory outcomes of apoptosis, necrosis and necroptosis. Biol. Chem. 395, 1163\u20131171 (2014).","journal-title":"Biol. Chem."},{"key":"599_CR29","first-page":"2035","volume":"46","author":"HH Boersma","year":"2005","unstructured":"Boersma, H. H. et al. Past, present, and future of annexin A5: from protein discovery to clinical applications. J. Nucl. Med. 46, 2035\u20132050 (2005).","journal-title":"J. Nucl. Med."},{"key":"599_CR30","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/nm1201-1347","volume":"7","author":"J Narula","year":"2001","unstructured":"Narula, J. et al. Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat. Med. 7, 1347\u20131352 (2001).","journal-title":"Nat. Med."},{"key":"599_CR31","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nprot.2009.143","volume":"4","author":"SE Logue","year":"2009","unstructured":"Logue, S. E., Elgendy, M. & Martin, S. J. Expression, purification and use of recombinant annexin V for the detection of apoptotic cells. Nat. Protoc. 4, 1383\u20131395 (2009).","journal-title":"Nat. Protoc."},{"key":"599_CR32","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.bbamcr.2008.01.030","volume":"1783","author":"HO van Genderen","year":"2008","unstructured":"van Genderen, H. O. et al. Extracellular annexin A5: functions of phosphatidylserine-binding and two-dimensional crystallization. Biochim. Biophys. Acta 1783, 953\u2013963 (2008).","journal-title":"Biochim. Biophys. Acta"},{"key":"599_CR33","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1007\/s10495-010-0503-y","volume":"15","author":"K Schutters","year":"2010","unstructured":"Schutters, K. & Reutelingsperger, C. Phosphatidylserine targeting for diagnosis and treatment of human diseases. Apoptosis 15, 1072\u20131082 (2010).","journal-title":"Apoptosis"},{"key":"599_CR34","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.cdd.4400817","volume":"8","author":"R Schlegel","year":"2001","unstructured":"Schlegel, R. & Williamson, P. Phosphatidylserine, a death knell. Cell Death Differ. 8, 551\u2013563 (2001).","journal-title":"Cell Death Differ."},{"key":"599_CR35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000024451","volume":"123","author":"S Martin","year":"2000","unstructured":"Martin, S. et al. Immunologic stimulation of mast cells leads to the reversible exposure of phosphatidylserine in the absence of apoptosis. Int. Arch. Allergy Immunol. 123, 249\u2013258 (2000).","journal-title":"Int. Arch. Allergy Immunol."},{"key":"599_CR36","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.4049\/jimmunol.164.3.1322","volume":"164","author":"SR Dillon","year":"2000","unstructured":"Dillon, S. R., Mancini, M., Rosen, A. & Schlissel, M. S. Annexin V binds to viable B cells and colocalizes with a marker of lipid rafts upon B cell receptor activation. J. Immunol. 164, 1322\u20131332 (2000).","journal-title":"J. Immunol."},{"key":"599_CR37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/cdd.2008.150","volume":"16","author":"G Kroemer","year":"2009","unstructured":"Kroemer, G. et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 16, 3\u201311 (2009).","journal-title":"Cell Death Differ."},{"key":"599_CR38","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00281-010-0228-6","volume":"33","author":"B Frey","year":"2011","unstructured":"Frey, B. & Gaipl, U. S. The immune functions of phosphatidylserine in membranes of dying cells and microvesicles. Semin. Immunopathol. 33, 497\u2013516 (2011).","journal-title":"Semin. Immunopathol."},{"key":"599_CR39","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.fertnstert.2005.06.046","volume":"85","author":"G Barroso","year":"2006","unstructured":"Barroso, G. et al. Mitochondrial membrane potential integrity and plasma membrane translocation of phosphatidylserine as early apoptotic markers: a comparison of two different sperm subpopulations. Fertil. Steril. 85, 149\u2013154 (2006).","journal-title":"Fertil. Steril."},{"key":"599_CR40","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nmat3776","volume":"12","author":"S Mura","year":"2013","unstructured":"Mura, S., Nicolas, J. & Couvreur, P. Stimuli-responsive nanocarriers for drug delivery. Nat. Mater. 12, 991\u20131003 (2013).","journal-title":"Nat. Mater."},{"key":"599_CR41","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.7150\/thno.34576","volume":"9","author":"CA Cheng","year":"2019","unstructured":"Cheng, C. A. et al. Supramolecular nanomachines as stimuli-responsive gatekeepers on mesoporous silica nanoparticles for antibiotic and cancer drug delivery. Theranostics 9, 3341\u20133364 (2019).","journal-title":"Theranostics"},{"key":"599_CR42","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.addr.2012.09.033","volume":"64","author":"L Brannon-Peppas","year":"2012","unstructured":"Brannon-Peppas, L. & Blanchette, J. O. Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev. 64, 206\u2013212 (2012).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"599_CR43","doi-asserted-by":"crossref","DOI":"10.1186\/1743-8977-4-10","volume":"4","author":"E Sadauskas","year":"2007","unstructured":"Sadauskas, E. et al. Kupffer cells are central in the removal of nanoparticles from the organism. Part. Fibre Toxicol. 4, 10 (2007).","journal-title":"Part. Fibre Toxicol."},{"key":"599_CR44","first-page":"E10871","volume":"114","author":"AJ Tavares","year":"2017","unstructured":"Tavares, A. J. et al. Effect of removing Kupffer cells on nanoparticle tumour delivery. Proc. Natl Acad. Sci. USA 114, E10871\u2013E10880 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"599_CR45","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1021\/ar4000339","volume":"46","author":"H Xu","year":"2013","unstructured":"Xu, H., Cao, W. & Zhang, X. Selenium-containing polymers: promising biomaterials for controlled release and enzyme mimics. Acc. Chem. Res. 46, 1647\u20131658 (2013).","journal-title":"Acc. Chem. Res."},{"key":"599_CR46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.semcdb.2015.02.006","volume":"40","author":"JH Kim","year":"2015","unstructured":"Kim, J. H., Lee, J., Park, J. & Gho, Y. S. Gram-negative and Gram-positive bacterial extracellular vesicles. Semin. Cell Dev. Biol. 40, 97\u2013104 (2015).","journal-title":"Semin. Cell Dev. Biol."},{"key":"599_CR47","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1093\/clinchem\/41.10.1522","volume":"41","author":"N Fogh-Andersen","year":"1995","unstructured":"Fogh-Andersen, N. et al. Composition of interstitial fluid. Clin. Chem. 41, 1522\u20131525 (1995).","journal-title":"Clin. Chem."},{"key":"599_CR48","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1083\/jcb.200108080","volume":"155","author":"PR Hoffmann","year":"2001","unstructured":"Hoffmann, P. R. et al. Phosphatidylserine (PS) induces PS receptor\u2013mediated macropinocytosis and promotes clearance of apoptotic cells. J. Cell Biol. 155, 649\u2013659 (2001).","journal-title":"J. Cell Biol."},{"key":"599_CR49","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1083\/jcb.200110066","volume":"155","author":"S Somersan","year":"2001","unstructured":"Somersan, S. & Bhardwaj, N. Tethering and tickling: a new role for the phosphatidylserine receptor. J. Cell Biol. 155, 501\u2013504 (2001).","journal-title":"J. Cell Biol."},{"key":"599_CR50","doi-asserted-by":"crossref","first-page":"7889","DOI":"10.7150\/thno.38583","volume":"9","author":"X Xu","year":"2019","unstructured":"Xu, X. et al. Advances in engineering cells for cancer immunotherapy. Theranostics 9, 7889\u20137905 (2019).","journal-title":"Theranostics"},{"key":"599_CR51","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.4049\/jimmunol.1200742","volume":"190","author":"OY Kim","year":"2013","unstructured":"Kim, O. Y. et al. Immunization with Escherichia coli outer membrane vesicles protects bacteria-induced lethality via Th1 and Th17 cell responses. J. Immunol. 190, 4092\u20134102 (2013).","journal-title":"J. Immunol."},{"key":"599_CR52","doi-asserted-by":"crossref","first-page":"10443","DOI":"10.1074\/jbc.M213071200","volume":"278","author":"A Castrillo","year":"2003","unstructured":"Castrillo, A., Joseph, S. B., Marathe, C., Mangelsdorf, D. J. & Tontonoz, P. Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages. J. Biol. Chem. 278, 10443\u201310449 (2003).","journal-title":"J. Biol. Chem."},{"key":"599_CR53","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.176.6.1693","volume":"176","author":"K Inaba","year":"1992","unstructured":"Inaba, K. et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte\/macrophage colony-stimulating factor. J. Exp. Med. 176, 1693\u20131702 (1992).","journal-title":"J. Exp. Med."}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-020-0599-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-020-0599-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-020-0599-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T22:55:44Z","timestamp":1670280944000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-020-0599-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,17]]},"references-count":53,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11]]}},"alternative-id":["599"],"URL":"https:\/\/doi.org\/10.1038\/s41551-020-0599-5","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,17]]},"assertion":[{"value":"29 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}